POVIDONE K25

Unresolved Excipient

Suggest One No specific molecular structure known for this excipient.
CAS
9003398
UNII
K0KQV10C35
SYNONYMS
ZINC ID(s)
Availability
Present in 0 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Analogs cannot be located as there is no structure provided for this compound. Try a search by name.

Dosages

Route Formulation Per Unit Dose
Oral Capsule 6.26MG
Oral Capsule, Extended Release 12.6MG
Oral Capsule, Sustained Action 17.79MG
Oral Capsule, Sustained Action, Hard Gelatin 12.6MG
Oral Granule, For Oral Suspension 0.27MG
Oral Solution 5%
Oral Suspension, Sustained Action 0.27MG
Oral Tablet 52MG
Oral Tablet (immed./comp. Release), Film Coated 54.47MG
Oral Tablet, Coated 40MG
Oral Tablet, Delayed Action 12.3MG
Oral Tablet, Delayed Action, Enteric Coated 20MG
Oral Tablet, Film Coated 22.5MG
Oral Tablet, Multilayer, Extended Release 1.8MG
Oral Tablet, Sustained Action, Coated
Oral-28 Tablet 4MG
Respiratory (inhalation) Aerosol, Metered 0.0001%

More Information

Usage Over Time

Comments